Skip to content
healthcare.dev

Burn Cream

NDC 69396-146, Benzalkonium Chloride, Lidocaine HCI, cream, from Trifecta Pharmaceuticals USA LLC.

Product NDC
69396-146
Status
Listed
Labeler
Trifecta Pharmaceuticals USA LLC
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M003
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69396-146 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE.005 g/g
  • BENZALKONIUM CHLORIDE.0013 g/g

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
69396-146-106939601461010 PACKET in 1 CARTON (69396-146-10) / .9 g in 1 PACKET
69396-146-256939601462525 PACKET in 1 CARTON (69396-146-25) / .9 g in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69396-146 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69396-146 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69396-146. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.